TKIM
CAS No. 326921-25-9
TKIM( —— )
Catalog No. M22546 CAS No. 326921-25-9
TKIM is a TWIK-related potassium channel 1 (TREK-1) inhibitor, binding to the pocket of the intermediate (IM) state of TREK-1.TKIM binds to the pocket of the IM state of TREK-1, which differs from the binding of common inhibitors, which bind to channels in the inactive state.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 88 | In Stock |
|
| 5MG | 82 | In Stock |
|
| 10MG | 126 | In Stock |
|
| 25MG | 224 | In Stock |
|
| 50MG | 308 | In Stock |
|
| 100MG | 412 | In Stock |
|
| 200MG | 554 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTKIM
-
NoteResearch use only, not for human use.
-
Brief DescriptionTKIM is a TWIK-related potassium channel 1 (TREK-1) inhibitor, binding to the pocket of the intermediate (IM) state of TREK-1.TKIM binds to the pocket of the IM state of TREK-1, which differs from the binding of common inhibitors, which bind to channels in the inactive state.
-
DescriptionTKIM is a TWIK-related potassium channel 1 (TREK-1) inhibitor, binding to the pocket of the intermediate (IM) state of TREK-1.TKIM binds to the pocket of the IM state of TREK-1, which differs from the binding of common inhibitors, which bind to channels in the inactive state. Overall, identified an allosteric ligand-binding site and a new mechanistic inhibitor for TREK-1, suggesting that IM states of ion channels may be promising druggable targets for use in discovering allosteric modulators.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetPotassium Channel
-
RecptorTREK-1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number326921-25-9
-
Formula Weight371.05
-
Molecular FormulaC18H14ClN3O2S?
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (672.33 mM)
-
SMILESClc1ccc(cc1)C(=O)NNC(=O)CSc1ccc2ccccc2n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ma Y , Luo Q , Fu J , et al. Discovery of an Inhibitor for the TREK-1 Channel Targeting an Intermediate Transition State of Channel Gating[J]. Journal of Medicinal Chemistry, 2020.
molnova catalog
related products
-
Glyburide
Glibenclamide(Glyburide) is a sulfonylurea compound that modulates insulin production.
-
BMS-813160
BMS-813160 is the first dual?CCR2/CCR5?antagonist to enter Clinical development for cardiovascular.
-
VU0071063
VU0071063 is a Kir6.2/SUR1 activator.
Cart
sales@molnova.com